Pricing Log in Create free account

Altimmune, Inc. (ALT) vs Tectonic Therapeutic, Inc. (TECX)

Altimmune, Inc. and Tectonic Therapeutic, Inc. are both Biotechnology companies. Altimmune, Inc. and Tectonic Therapeutic, Inc. are of similar size ($383.2M and $379.7M). Across the 11 metrics below, Altimmune, Inc. leads on 6 and Tectonic Therapeutic, Inc. on 5.

Valuation

Metric ALT TECX Biotechnology median
P/E n/m n/m 10.60
P/S 8,304.65 n/m 9.40
P/B 0.81 1.75 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1,969.72 n/m 9.02
Earnings yield (37.86%) (22.16%) (32.88%)
Free cash flow yield (20.09%) (18.51%) (23.13%)

Profitability

Metric ALT TECX Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (28.87%) (33.80%) (51.96%)
Return on assets (25.58%) (32.23%) (46.06%)
Return on invested capital (34.30%) 0.00% 0.00%

Growth

Metric ALT TECX Biotechnology median
Revenue growth (TTM) 130.00% — 6.76%
EPS growth (last fiscal year) 25.37% 40.70% 29.88%
Revenue growth, 5-year CAGR (65.33%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALT TECX Biotechnology median
Debt to equity 0.07 0.00 0.00
Current ratio 26.78 22.29 4.97
Net debt to EBITDA 2.49 3.08 1.01

Dividend

Metric ALT TECX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALT TECX Biotechnology median
Market cap 383.20m 379.65m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack